Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-524-296"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.45.2-524-296"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"I voted in favour of this report supporting the mobilisation of EUR 4 325 854 from the European Globalisation Adjustment Fund targeting 700 of the 987 redundancies that have occurred in the company AstraZeneca, which operates in the pharmaceutical sector in Lund in Sweden. The EGF provides additional support to workers who are suffering the consequences of major structural changes in world trade patterns and to assist their reintegration into the labour market. Sweden has submitted an application for EGF assistance for redundancies that meets the conditions of the EGF Regulation. It must now be ensured that the EGF assistance is used to support the dismissed workers’ reintegration into the labour market and must not replace actions which are the responsibility of companies by virtue of national law or collective agreements, nor measures restructuring companies or sectors."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples